Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.

Gao C, Pang H, Luo XG, Ren Y, Shang H, He ZY.

J Neurol. 2013 Nov;260(11):2884-9. doi: 10.1007/s00415-013-7086-9. Epub 2013 Aug 30. Erratum in: J Neurol. 2014 Jan;261(1):250.

PMID:
24046064
2.

The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.

Kim JM, Lee JY, Kim HJ, Kim JS, Shin ES, Cho JH, Park SS, Jeon BS.

Parkinsonism Relat Disord. 2010 Feb;16(2):85-8. doi: 10.1016/j.parkreldis.2009.10.004. Epub 2009 Oct 23.

PMID:
19854095
3.

Correlation between LRRK2 gene G2385R polymorphisms and Parkinson's disease.

Yan H, Ma Q, Yang X, Wang Y, Yao Y, Li H.

Mol Med Rep. 2012 Oct;6(4):879-83. doi: 10.3892/mmr.2012.1008. Epub 2012 Jul 26.

PMID:
22842796
4.

The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies.

Xie CL, Pan JL, Wang WW, Zhang Y, Zhang SF, Gan J, Liu ZG.

Neurol Sci. 2014 Oct;35(10):1495-504. doi: 10.1007/s10072-014-1878-2. Epub 2014 Jul 16. Review.

PMID:
25027012
5.

Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.

Li DW, Gu Z, Wang C, Ma J, Tang BS, Chen SD, Chan P.

J Neural Transm (Vienna). 2015 May;122(5):661-7. doi: 10.1007/s00702-014-1281-4. Epub 2014 Jul 26.

PMID:
25062988
6.

Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.

Cai J, Lin Y, Chen W, Lin Q, Cai B, Wang N, Zheng W.

Neurol Sci. 2013 Nov;34(11):2001-6. doi: 10.1007/s10072-013-1436-3. Epub 2013 Apr 30.

PMID:
23624603
7.

Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.

Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, Barrett MJ, Cabassa J, Groves M, Hunt AL, Lubarr N, San Luciano M, Miravite J, Palmese C, Sachdev R, Sarva H, Severt L, Shanker V, Swan MC, Soto-Valencia J, Johannes B, Ortega R, Fahn S, Cote L, Waters C, Mazzoni P, Ford B, Louis E, Levy O, Rosado L, Ruiz D, Dorovski T, Pauciulo M, Nichols W, Orr-Urtreger A, Ozelius L, Clark L, Giladi N, Bressman S, Marder KS.

Mov Disord. 2013 Dec;28(14):1966-71. doi: 10.1002/mds.25647. Epub 2013 Oct 15.

8.

Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.

Yahalom G, Kaplan N, Vituri A, Cohen OS, Inzelberg R, Kozlova E, Korczyn AD, Rosset S, Friedman E, Hassin-Baer S.

Parkinsonism Relat Disord. 2012 Nov;18(9):1039-41. doi: 10.1016/j.parkreldis.2012.05.014. Epub 2012 Jun 13.

PMID:
22703868
9.

Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.

Liu J, Zhou Y, Wang C, Wang T, Zheng Z, Chan P.

Parkinsonism Relat Disord. 2012 Feb;18(2):140-3. doi: 10.1016/j.parkreldis.2011.09.002. Epub 2011 Sep 16.

PMID:
21924942
10.

Analysis of the LRRK2 Gly2385Arg variant in Alzheimer's disease in Taiwan.

Chang TY, Kuo HC, Lu CS, Wu-Chou YH, Huang CC.

Parkinsonism Relat Disord. 2010 Jan;16(1):28-30. doi: 10.1016/j.parkreldis.2009.06.009. Epub 2009 Jul 28.

PMID:
19640773
11.

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.

Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW; International LRRK2 Consortium.

Lancet Neurol. 2008 Jul;7(7):583-90. doi: 10.1016/S1474-4422(08)70117-0. Epub 2008 Jun 6.

12.

Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.

Sun Q, Wang T, Jiang TF, Huang P, Li DH, Wang Y, Xiao Q, Liu J, Chen SD.

Aging Dis. 2016 May 27;7(3):230-6. doi: 10.14336/AD.2015.1026. eCollection 2016 May.

13.

MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.

Dan X, Wang C, Ma J, Feng X, Wang T, Zheng Z, Chan P.

Neurobiol Aging. 2014 Jul;35(7):1780.e7-1780.e10. doi: 10.1016/j.neurobiolaging.2014.01.025. Epub 2014 Jan 25.

PMID:
24559644
14.

LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.

Yu L, Hu F, Zou X, Jiang Y, Liu Y, He X, Xi J, Liu L, Liu Z, He L, Xu Y.

Brain Res. 2009 Nov 3;1296:113-6. doi: 10.1016/j.brainres.2009.08.047. Epub 2009 Aug 20.

PMID:
19699188
15.

LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.

An XK, Peng R, Li T, Burgunder JM, Wu Y, Chen WJ, Zhang JH, Wang YC, Xu YM, Gou YR, Yuan GG, Zhang ZJ.

Eur J Neurol. 2008 Mar;15(3):301-5. doi: 10.1111/j.1468-1331.2007.02052.x. Epub 2008 Jan 14.

PMID:
18201193
16.

Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.

Cao M, Gu ZQ, Li Y, Zhang H, Dan XJ, Cen SS, Li DW, Chan P.

Neurosci Bull. 2016 Dec;32(6):572-576. Epub 2016 Oct 3.

PMID:
27699718
17.

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.

Farrer MJ, Stone JT, Lin CH, Dächsel JC, Hulihan MM, Haugarvoll K, Ross OA, Wu RM.

Parkinsonism Relat Disord. 2007 Mar;13(2):89-92. Epub 2007 Jan 10.

PMID:
17222580
18.

The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.

Rudenko IN, Kaganovich A, Hauser DN, Beylina A, Chia R, Ding J, Maric D, Jaffe H, Cookson MR.

Biochem J. 2012 Aug 15;446(1):99-111. doi: 10.1042/BJ20120637.

19.

Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.

Hong JH, Kim YK, Park JS, Lee JE, Oh MS, Chung EJ, Kim JY, Sung YH, Lyoo CH, Lee JH, Kwon DY, Kim HS, Shin HW, Park SA, Park IS, Kim JS, Lee PH, Koh SB, Baik JS, Kim SJ, Ma HI, Kim JW, Kim YJ.

J Clin Neurosci. 2017 Feb;36:108-113. doi: 10.1016/j.jocn.2016.10.013. Epub 2016 Nov 10.

PMID:
27839916
20.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Ferraris A, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Farrer MJ; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Lancet Neurol. 2011 Oct;10(10):898-908. doi: 10.1016/S1474-4422(11)70175-2. Epub 2011 Aug 30. Erratum in: Lancet Neurol. 2011 Oct;10(10):870.

Supplemental Content

Support Center